Informizely customer feedback surveys

[Skip to content]

Southern Health
Search our Site

Take Control

SANOFI

Effectiveness of patient-managed insulin dose compared to doctor-managed insulin dose

The aim of this study is to evaluate the effectiveness of a patient managing their own insulin adjustment (using a schedule) compared to when a doctor manages the insulin adjustment. The study drug Toujeo will be administered once a day by subcutaneous injection.


What does it involve?

Before taking part in the study a full medical history and examination must be taken to ensure that it is safe for you to take part.

The study will consist of 3 periods and 16 visits (6 clinic visits and 10 phone call visits)

Period 1: the 2-week screening period

Period 2: the 24-week open-label treatment period

Period 3: a safety follow-up period

Overall the duration of the study for each patient is approximately 28 weeks.


Inclusion Criteria
  • Patients with Type 2 diabetes diagnosed for at least 1 year at the time of screening
  • Treated with ≥1 non-insulin antihyperglycemic drug(s) with or without a basal insulin, for at least 6 months.


To refer potential participants or to request further information, please contact the research team:

Email: Chantelle.moorbey@southernhealth.nhs.uk

Tel: 023 7047 5258

I would like to:

Return to Diabetes Studies

Return to Current Studies

Telephone the Research Team on 02380475258

Email the Research Team